Clearside Biomedical Inc (CLSD)
1.29
-0.02
(-1.53%)
USD |
NASDAQ |
May 06, 13:34
Clearside Biomedical Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 83.47% |
| June 30, 2023 | 79.08% |
| Date | Value |
|---|---|
| March 31, 2023 | |
| December 31, 2022 | 38.18% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
38.18%
Minimum
Dec 2022
83.47%
Maximum
Sep 2023
66.91%
Average
79.08%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Cassava Sciences Inc | -- |
| Heron Therapeutics Inc | 71.12% |
| Actinium Pharmaceuticals Inc | -- |
| Karyopharm Therapeutics Inc | 95.60% |
| Ocular Therapeutix Inc | 90.64% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -79.77% |
| Profit Margin (Quarterly) | -76.15% |
| Operating Margin (Quarterly) | -45.94% |
| Return on Net Operating Assets | -828.2% |